BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25489300)

  • 41. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
    Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
    Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of percutaneous patent foramen ovale closure on migraine headaches in patients with history of ischemic neurological events.
    Przemysław W; Spisak-Borowska K; Bochenek T; Konarska-Kuszewska E; Machowski J; Trusz-Gluza M; Bajor G; Mizia-Stec K; Giblett JP; Calvert PA
    Postepy Kardiol Interwencyjnej; 2020 Sep; 16(3):315-320. PubMed ID: 33597997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S; Russo F; Campana C; Agostoni E
    Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P
    Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detecting Patent Foramen Ovale after Cryptogenic Stroke - A Single Center Experience in Taiwan.
    Lin TY; Fu YC; Jan SL; Lin MC
    Acta Cardiol Sin; 2022 May; 38(3):373-380. PubMed ID: 35673343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patent Foramen Ovale Closure in the Setting of Cryptogenic Stroke: A Meta-Analysis of Five Randomized Trials.
    Garg L; Haleem A; Varade S; Sivakumar K; Shah M; Patel B; Agarwal M; Agrawal S; Leary M; Kluck B
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2484-2493. PubMed ID: 29805084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
    Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
    Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Dellborg M
    Int J Cardiol; 2015 Sep; 195():293-9. PubMed ID: 26056962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population.
    Moon J; Kang WC; Kim S; Oh PC; Park YM; Chung WJ; Choi DY; Lee JY; Lee YB; Hwang HY; Ahn T
    Yonsei Med J; 2016 May; 57(3):621-5. PubMed ID: 26996560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implications of detection of foramen ovale patent after cryptogenic ischemic stroke.
    Marinheiro R; Parreira L; Amador P; Silvestre I; Antunes C; Caria R
    J Echocardiogr; 2019 Mar; 17(1):44-51. PubMed ID: 30008156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke.
    West BH; Noureddin N; Mamzhi Y; Low CG; Coluzzi AC; Shih EJ; Gevorgyan Fleming R; Saver JL; Liebeskind DS; Charles A; Tobis JM
    Stroke; 2018 May; 49(5):1123-1128. PubMed ID: 29636424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
    Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
    Davies A; Ekmejian A; Collins N; Bhagwandeen R
    Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
    Sadrameli SS; Gadhia RR; Kabir R; Volpi JJ
    Cureus; 2018 Aug; 10(8):e3213. PubMed ID: 30405989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.